Cyclopharm Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced total revenue was AUD 8.481 million compared to AUD 5.770 million a year ago. Net loss was AUD 3.928 million compared to AUD 5.649 million a year ago. Basic loss per share from continuing operations was AUD 0.0446 compared to AUD 0.0735 a year ago.